Christopher Senner

Track

Insider profile

Currently holds positions in Exelixis Inc and Quince Therapeutics Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Exelixis Inc July 15, 2015 -
Independent Director Quince Therapeutics Inc March 1, 2019 -
Christopher Senner's trades of Exelixis Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
265.22
Quantity 16,678 +31.5%
Value US$4,879,480
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
171.20
Quantity 20,100
Value US$1,178,513
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
13.09
Quantity 13,346 -39.6%
Value US$630,668
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
43.67
Quantity 30,617
Value US$1,337,035
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
43.00
Quantity 34,278 -3.2%
Value US$1,473,954
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
43.00
Quantity 34,278
Value US$1,473,964
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
46.00
Quantity 100,000
Value US$4,600,000
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
46.00
Quantity 100,000 -9.4%
Value US$4,600,000
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
36.14
Quantity 29,314 -3.6%
Value US$1,059,408
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
36.14
Quantity 29,314
Value US$1,059,370
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
27.17
Quantity 125,000
Value US$3,396,250
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
27.19
Quantity 125,000 -14.8%
Value US$3,398,750
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
20.68
Quantity 60,000 -9.5%
Value US$1,240,800
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
20.51
Quantity 60,000 -9.5%
Value US$1,230,600
US Exelixis Inc (EXEL)
Transaction date
Proposed sale
Price
19.75
Quantity 120,000
Value US$2,370,511
US Exelixis Inc (EXEL)
Transaction date
Planned sale
Price
25.00
Quantity 30,000 -10.9%
Value US$750,000
US Exelixis Inc (EXEL)
Transaction date
Planned sale
Price
25.00
Quantity 10,000 -7.3%
Value US$250,000
US Exelixis Inc (EXEL)
Transaction date
Planned sale
Price
25.00
Quantity 20,000 -13.5%
Value US$500,000
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
25.81
Quantity 78,583 -39.4%
Value US$2,028,227
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
25.80
Quantity 21,417 -15.1%
Value US$552,559
US Exelixis Inc (EXEL)
Transaction date
Planned sale
Price
20.70
Quantity 36,261 -24.4%
Value US$750,603
US Exelixis Inc (EXEL)
Transaction date
Sale
Price
19.70
Quantity 8,791 -5.6%
Value US$173,183
US Exelixis Inc (EXEL)
Transaction date
Planned sale
Price
22.80
Quantity 11,000 -9.9%
Value US$250,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-19 2026-05-18
US Exelixis Inc (EXEL)
S Sale
16,678 +31.5%
265.22
US$4,879,480 		16,678 +31.5% 265.22 US$4,879,480
2026-05-18 2026-05-18
US Exelixis Inc (EXEL)
PrS Proposed sale
20,100
171.20
US$1,178,513 		20,100 171.20 US$1,178,513
2026-02-18 2026-02-17
US Exelixis Inc (EXEL)
S Sale
13,346 -39.6%
13.09
US$630,668 		13,346 -39.6% 13.09 US$630,668
2026-02-17 2026-02-17
US Exelixis Inc (EXEL)
PrS Proposed sale
30,617
43.67
US$1,337,035 		30,617 43.67 US$1,337,035
2026-02-18 2026-02-13
US Exelixis Inc (EXEL)
S Sale
34,278 -3.2%
43.00
US$1,473,954 		34,278 -3.2% 43.00 US$1,473,954
2026-02-13 2026-02-13
US Exelixis Inc (EXEL)
PrS Proposed sale
34,278
43.00
US$1,473,964 		34,278 43.00 US$1,473,964
2025-05-16 2025-05-16
US Exelixis Inc (EXEL)
PrS Proposed sale
100,000
46.00
US$4,600,000 		100,000 46.00 US$4,600,000
2025-05-16 2025-05-16
US Exelixis Inc (EXEL)
S Sale
100,000 -9.4%
46.00
US$4,600,000 		100,000 -9.4% 46.00 US$4,600,000
2025-02-26 2025-02-24
US Exelixis Inc (EXEL)
S Sale
29,314 -3.6%
36.14
US$1,059,408 		29,314 -3.6% 36.14 US$1,059,408
2025-02-24 2025-02-24
US Exelixis Inc (EXEL)
PrS Proposed sale
29,314
36.14
US$1,059,370 		29,314 36.14 US$1,059,370
2024-08-09 2024-08-09
US Exelixis Inc (EXEL)
PrS Proposed sale
125,000
27.17
US$3,396,250 		125,000 27.17 US$3,396,250
2024-08-09 2024-08-09
US Exelixis Inc (EXEL)
S Sale
125,000 -14.8%
27.19
US$3,398,750 		125,000 -14.8% 27.19 US$3,398,750
2023-08-07 2023-08-04
US Exelixis Inc (EXEL)
S Sale
60,000 -9.5%
20.68
US$1,240,800 		60,000 -9.5% 20.68 US$1,240,800
2023-08-07 2023-08-03
US Exelixis Inc (EXEL)
S Sale
60,000 -9.5%
20.51
US$1,230,600 		60,000 -9.5% 20.51 US$1,230,600
2023-08-03 2023-08-03
US Exelixis Inc (EXEL)
PrS Proposed sale
120,000
19.75
US$2,370,511 		120,000 19.75 US$2,370,511
2021-01-14 2021-01-12
US Exelixis Inc (EXEL)
PlS Planned sale
30,000 -10.9%
25.00
US$750,000 		30,000 -10.9% 25.00 US$750,000
2020-10-09 2020-10-08
US Exelixis Inc (EXEL)
PlS Planned sale
10,000 -7.3%
25.00
US$250,000 		10,000 -7.3% 25.00 US$250,000
2020-09-15 2020-09-15
US Exelixis Inc (EXEL)
PlS Planned sale
20,000 -13.5%
25.00
US$500,000 		20,000 -13.5% 25.00 US$500,000
2020-05-08 2020-05-08
US Exelixis Inc (EXEL)
S Sale
78,583 -39.4%
25.81
US$2,028,227 		78,583 -39.4% 25.81 US$2,028,227
2020-05-08 2020-05-07
US Exelixis Inc (EXEL)
S Sale
21,417 -15.1%
25.80
US$552,559 		21,417 -15.1% 25.80 US$552,559
2019-05-03 2019-05-03
US Exelixis Inc (EXEL)
PlS Planned sale
36,261 -24.4%
20.70
US$750,603 		36,261 -24.4% 20.70 US$750,603
2018-11-30 2018-11-30
US Exelixis Inc (EXEL)
S Sale
8,791 -5.6%
19.70
US$173,183 		8,791 -5.6% 19.70 US$173,183
2017-03-03 2017-03-03
US Exelixis Inc (EXEL)
PlS Planned sale
11,000 -9.9%
22.80
US$250,800 		11,000 -9.9% 22.80 US$250,800